Does Prophylactic Antibiotic Administration Time Effect Surgical Site Infection Rates in Colorectal Surgery? by Desjardins, Ashley E.
Rhode Island College
Digital Commons @ RIC
Master's Theses, Dissertations, Graduate Research
and Major Papers Overview
Master's Theses, Dissertations, Graduate Research
and Major Papers
2016
Does Prophylactic Antibiotic Administration Time
Effect Surgical Site Infection Rates in Colorectal
Surgery?
Ashley E. Desjardins
Rhode Island College, asmith_3293@email.ric.edu
Follow this and additional works at: https://digitalcommons.ric.edu/etd
Part of the Perioperative, Operating Room and Surgical Nursing Commons
This Major Paper is brought to you for free and open access by the Master's Theses, Dissertations, Graduate Research and Major Papers at Digital
Commons @ RIC. It has been accepted for inclusion in Master's Theses, Dissertations, Graduate Research and Major Papers Overview by an
authorized administrator of Digital Commons @ RIC. For more information, please contact digitalcommons@ric.edu.
Recommended Citation
Desjardins, Ashley E., "Does Prophylactic Antibiotic Administration Time Effect Surgical Site Infection Rates in Colorectal Surgery?"
(2016). Master's Theses, Dissertations, Graduate Research and Major Papers Overview. 169.
https://digitalcommons.ric.edu/etd/169
 
 
  
 
 
 
 
 
DOES PROPHYLACTIC ANTIBIOTIC ADMINISTRATION TIME  
EFFECT SURGICAL SITE INFECTION RATES 
IN COLORECTAL SURGERY? 
 
 
 
 
A Major Paper Presented 
 
by 
 
Ashley E. Desjardins, BSN, RN, SRNA 
 
 
 
 
 
 
 
 
 
 
 
 
Approved:   
 
Committee Chairperson          _________________________________    __________ 
                                                                                                                       (Date) 
Committee Members              _________________________________    __________ 
                                                                                                                       (Date) 
                                                _________________________________    __________ 
                                                                                                                       (Date) 
Director of Master’s Program _________________________________    __________ 
                                                                                                                       (Date) 
Dean, School of Nursing        _________________________________    __________                                                                                                                        
           (Date)                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOES PROPHYLACTIC ANTIBIOTIC ADMINISTRATION  
TIME EFFECT SURGICAL SITE INFECTIONS RATES  
IN COLORECTAL SURGERY? 
 
 
 
 
 
by 
 
 
Ashley E. Desjardins, BSN, RN, SRNA 
 
A Major Paper Submitted in Partial Fulfillment 
of the Requirements for the Degree of  
Master of Science in Nursing 
in 
The School of Nursing 
Rhode Island College 
2016 
 
 
 
Abstract 
Colorectal surgery is known for having a high risk of surgical site infection (SSI).  
Prior research has suggested that administering prophylactic antibiotics prior to colorectal  
surgery may prevent SSI.  This led to the question: In adult surgical patients having  
colorectal surgeries, does prophylactic antibiotic administration time effect surgical site  
infection rates within 30 days of surgery?  A comprehensive literature review was  
completed followed by a detailed screening for inclusion and exclusion criteria, resulting  
in a final total of nine studies.  Detailed data were collected for each study, followed by  
completion of critical appraisal checklists appropriate to the study design.  Quality of the  
evidence was assessed across studies.  Six of the studies were cohort studies, with only  
two randomized controlled trials and one systematic review.  Results indicated that there  
is insufficient evidence to support a definite course of action for timing of antibiotic  
prophylaxis for colorectal surgery.  The certified registered nurse anesthetist (CRNA)  
should be aware of the recommendations to administer antibiotics for colorectal surgery  
before the surgical incision based on the results of this systematic review as timing of  
administration can affect SSI rates.  It is recommended to carefully consider antibiotic  
selection and timing when administering antibiotics for colorectal surgery.  
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Does Prophylactic Antibiotic Administration Time Effect 
Surgical Site Infection Rates In Colorectal Surgery? 
Background/Statement of the Problem  
 Surgical wound infections (SSIs) are often preventable.  Research reflects a  
decrease in morbidity and SSI rates in relation to prophylactic antibiotic administration  
(Gustafsson et al., 2013).  In 2013, guidelines for antibiotic prophylaxis were established  
by the American Society of Health-System Pharmacists (ASHP), the Infectious Disease  
Society of America (IDSA), the Surgical Infection Society (SIS), and Society for  
Healthcare Epidemiology of America (SHEA).  However, not all institutions and  
providers follow these same guidelines.  Based on the type of surgery, researchers  
recommend that appropriate antibiotic timing, selection, and route of administration  
needs further research (Nelson, Gladman, & Barbateskovic, 2014).  Colorectal surgery is  
known for having a high risk of surgical site infection.  In a study by Dettenkofer et al.  
(2002) of perioperative antibiotic prophylaxis for colorectal and hip surgeries, it was  
found that there was uncertainty related to appropriate timing of perioperative antibiotic  
administration and its duration.  Previous research has shown that giving prophylactic  
antibiotics prior to colorectal surgery prevents SSIs (Nelson et al., 2014).  This lead to the  
research question: In adult surgical patients having colorectal surgeries, does prophylactic  
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antibiotic administration time effect surgical site infection rates within 30 days of  
surgery?  The purpose of this systematic review was to examine the relationship between  
SSI rates and prophylactic antibiotic administration time in adults having colorectal  
surgeries.  
Next, the review of the literature will be presented.  
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Literature Review 
A literature search was conducted using the following key words: “Antibiotic  
Prophylaxis”, “Colorectal Surgery”, “Timing”, “Surgical Site Infection”, and “Surgical  
Care Improvement Program”.  CINAHL, PubMed, Cochrane, and Google Scholar  
produced relevant literature for analysis and evaluation.  The literature search was limited  
to studies no older than 15 years.  The following research studies have been summarized. 
Surgical Site Infections 
A SSI is an infection that occurs after surgery in the area of the body where the  
surgery was performed (Centers for Disease Control and Prevention [CDC], 2012).   
Surgical site infections can sometimes be superficial and involve only the skin, while  
other SSIs are more severe and can involve tissues below the skin, organs, or implanted  
devices (CDC).  Surgical site infections have been shown to increase readmission rates,  
length of stay, and costs for patients (Institute for Healthcare Improvement [IHI], 2012).   
Surgical site infection prevention measures include appropriate hair removal, use of  
prophylactic antibiotics, controlled postoperative glucose levels for cardiac patients, and  
immediate normothermia for colorectal surgery patients post-operatively.  If implemented  
correctly, these measures can drastically decrease the incidence of SSIs (IHI).  The  
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economic costs of SSIs are considerable; however, there are extreme variations in cost  
between minor superficial infections ranging from less than $400 up to $299,237 for  
complex infections (Alexander, Solomkin, & Edwards, 2011).  In the 1990s, the median  
cost for hospitalization for SSIs was $7,531 and $3,844 for patients without SSIs.  The  
increase in cost for SSIs was $2,671 for colon surgery (Alexander et al.).  A more current  
study evaluated length of stay and expenses associated with elective colorectal surgery  
SSIs.  It was found that SSI was associated with a $30,000 increase in cost for each  
hospital discharge (Eagye & Nicolau, 2009).       
Surgical Site Infections and Colorectal Surgery 
Colorectal surgery is linked with the highest risk of SSI due to the large amount  
of bacteria in the colon and rectum (Ishikawa et al., 2014).  The occurrence of SSIs after  
colorectal surgery have been reported to range between 5% and 26% (Ishikawa et al.).   
Ho et al. (2011) noted that among elective procedures, colorectal surgery has the highest  
occurrence of SSI, with infection rates varying from 3% to 43%, depending on the  
method of follow-up and SSI definition used (Ho et al.).   
Timing and Decreased Incidence of SSI in Colorectal Surgery.  Ho et al.  
(2011) attempted to identify adherence to a set of guidelines for antibiotic administration  
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and to assess risk for SSIs.  It was hypothesized that compliance with the guidelines  
would decrease the occurrence of SSIs.  Six hundred five patients having colorectal  
surgeries with anastomosis between June 2001 and July 2008 were selected randomly.   
Data were gathered via a retrospective chart review of patients having surgeries at the  
New York Presbyterian Hospital and Weill Cornell Medical Center using the CDC  
definition for SSI.  A statistical program known as “STATA/IC” was used for data  
analysis.  The first antibiotic dose was given to 361 patients within 30 minutes of  
incision, to 202 patients greater than 30 minutes before incision and to 22 patients after  
incision.  Results indicated that increased occurrence of SSIs correlated with early  
administration of prophylactic antibiotics, specifically greater than 30 minutes prior to  
incision (OR 1.725, 95% CI 1.147-2.596).  Documentation of exact time of  
administration of antibiotics was not clear if administered before patients arrived in the  
operating room, which was one of the limitations of this study.  Use of bowel preparation  
and oral antibiotics were not examined in this study and the sample size was small.  It  
was recommended that research be continued in order to improve guidelines for  
appropriate antibiotic administration timing and repeat dosing for colorectal procedures  
(Ho et al.).    
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A review by Gustafsson et al. (2013) examined current recommendations related  
to perioperative treatment in colorectal surgery based on the Enhanced Recovery After  
Surgery (ERAS) care pathway.  The ERAS Society for Perioperative Care was started by  
the previous ERAS Study Group and was formed in 2010.  The Society aims to improve  
perioperative care through research, education, and implementation of best practice.  The  
ERAS care pathway includes evidence-based treatments for the perioperative period  
made into a standardized protocol.   
The Gustafsson et al. (2013) review was conducted to identify the most current  
literature related to appropriate perioperative care for colon surgery.  Literature was  
gathered from Cochrane, EMBASE, and Medline with publications dated from 1966 to  
2012.  Mainly meta-analyses, randomized controlled trials (RCTs), and large cohort  
studies were included in this review.  The studies were individually analyzed for  
relevance and further examined by the senior author and committee members of ERAS.   
Both the Cochrane checklist and the GRADE system were used to assess quality.  With a  
recommendation grade of “high” and an evidence level of “strong”, it was found that the  
most appropriate time to administer intravenous (IV) antibiotics is 30 to 60 minutes prior  
to the surgical incision for colorectal surgery.  One study by Steinberg et al. (2009) was  
7 
 
used to support this recommendation.  In this study, the overall association between  
timing and infection risk was found to be significant (P = 0.04).  Infection risk after  
antibiotic administration within 30 minutes before incision was 1.6% compared with  
2.4% associated with antibiotic administration 31 to 60 minutes prior to surgery (odds  
ratio [OR] 1.74; 95% confidence interval 0.98 –3.04) (Steinberg et al.).  However,  
appropriate timing of oral antibiotic administration prior to colon surgery requires more  
investigation because the use of oral antibiotics has not been examined without  
mechanical bowel preparation (Gustafsson et al.).   
Timing and Decreased Incidence of SSI in Mixed Surgeries.  Another study by  
Weber et al. (2008) aimed to determine specific information about the most appropriate  
timing for perioperative antibiotic prophylaxis.  Weber et al. organized a prospective  
observational cohort study at a university hospital where timing of antimicrobial  
prophylaxis was examined based on SSI occurrence in 3,836 surgeries.  Cefuroxime 1.5g  
IV was administered as a single dose to each patient along with metronidazole 500mg IV  
for colorectal surgeries.  Weber et al. demonstrated a decreased occurrence of SSI rates  
when cefuroxime and metronidazole were administered 30 to 60 minutes before incision  
for procedures including colorectal surgery.  Analyses showed a significant increase in  
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the incidence of SSIs when antibiotic prophylaxis was administered during the last half  
hour of surgery (P < 0.001) and during the last 60 to 120 minutes of surgery (P = 0.035)  
as compared with 30 to 59 minutes before surgical incision (Weber et al.).  It was  
concluded that when IV cefuroxime was given for antibiotic prophylaxis, administration  
30 to 59 minutes prior to incision is more effective than during the last half hour (Weber  
et al.). 
Conversely, several current studies have failed to show decreased incidence of  
SSI with adherence to SCIP recommendations for prophylactic antibiotic administration  
time.  Pastor et al. (2010) hypothesized that the incidence of SSI would be decreased with  
the application of SCIP prevention measures.  A multidisciplinary team was assembled to  
put SCIP infection prevention measures into effect and monitor adherence.  Study  
participants included patients having non-emergent colorectal surgeries with an  
abdominal incision.  The sample included 491 patients having surgery at a tertiary  
institution.  Subjects were assigned to either the first 14-month group or the second 14- 
month group in order to compare and analyze data from each group.  Patient  
characteristics were compared during the two time periods by use of an independent t test  
for continuous variables and the Pearson test for categorical variables.  Compliance and  
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rate of SSI was determined by linear regression.  A P value of <.05 was considered to be  
statistically significant.  This study showed an increase in adherence to SCIP measures  
but without a decrease in SSI related to compliance for each individual case.  A 95% rate  
of compliance was achieved for timing of antibiotic prophylaxis, identified as starting  
administration within 60 minutes of surgical incision (P = .002).  The SSI rate between  
groups was similar at 18.9 % and 19.4 %.  Overall, there was a 19% rate of SSI after  
elective colorectal surgery.  Compliance with re-dosing of antibiotics was a challenge for  
prolonged surgery due to a lack of documentation and timing of administration.   
Antibiotic discontinuation before 24 hours after surgery also remained a challenge.  It  
was recommended that the practice of oral antibiotic prophylaxis and mechanical bowel  
preparation for colorectal surgery be further researched.  The sample size for this study  
was somewhat small, limiting its application to other populations (Pastor et al.).   
In a study by Hawn et al. (2011), SCIP guidelines were implemented and  
evaluated to determine if following the guidelines would result in a decreased incidence  
of SSI rates within 30 days of a surgical procedure.  Data were gathered from 2005 to  
2009 from the National Veterans’ Affairs Surgical Quality Improvement Program  
(VASQIP) on both compliance to SCIP measures and SSI incidence.  This was a  
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retrospective cohort study that also examined adherence to five SCIP measures including  
timely prophylactic antibiotic administration: SCIP-inf 1.  Five types of surgeries  
including cardiac, colorectal, hip or knee arthroplasty, arterial vascular, and hysterectomy  
were done at Veterans’ Affairs hospitals and included among the 60,853 surgeries used  
for analysis in this study.  Of this number of surgeries, 39,149 surgical cases were  
evaluated with the measurement of SCIP-inf 1.  A total of 15,444 colorectal surgeries  
were included in this study.  The overall SSI rate was 6.2% and 11.3% for colorectal  
surgeries.  After adjusting for the procedure and patient variables, the results indicated  
that compliance with the SCIP measures did not correlate with a lower incidence of SSI.   
For the timely antibiotic measure, an adjusted OR was determined to be 0.90 with a 95%  
CI for 29,042 cases.  In addition, this study’s VA population was mostly men, which  
could make a generalization to women difficult (Hawn et al.). 
 A more recently published study conducted by similar authors focused  
specifically on timing of surgical antibiotic prophylaxis and included subjects from the  
same population as in the earlier study.  Hawn et al. (2013) aimed to discover the  
correlation between antibiotic administration time and SSI rates within 30 days  
postoperatively.  The design and database from the previous study were repeated in this  
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study.  There were a total of 34,459 patients having one of the five types of surgery  
included in this research study.  Antibiotics were administered at a median of 28 minutes  
before surgical incision and 1,497 patients (4.6%) developed an SSI.  As compared with  
procedures with antibiotic administration within 60 minutes before incision, higher SSI  
rates were present for timing greater than 60 minutes before incision, but not after  
incision.  Generalized additive models (GAMs) were used to determine the correlation  
between SSI and timing of antibiotic administration.  In unadjusted generalized additive  
models, a significant nonlinear relationship was present between prophylactic antibiotic  
timing and SSI with timing as a continuous variable (P = .01).  In generalized additive  
models adjusted for procedure, patient, and antibiotic variables, no significant correlation  
between prophylactic antibiotic timing and SSI was seen (P = 0.26 - 0.85).  This was true  
for 5,469 colorectal surgeries (adjusted OR 0.7; 95% CI).  Therefore, the researchers felt  
that there was not enough evidence to recommend compliance to this SCIP measure.   
Based on the findings, it was also stated that there are several variables that could affect  
timing associated with SSI rates.  Researchers should take into account the patient  
population and antibiotic being used.  A limitation of this study was that more men than  
women were included, so a generalization to women cannot be made.  It was  
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recommended that further research address appropriate antibiotic selection and repeat  
dosing (Hawn et al.).        
 Ishikawa et al. (2014) conducted research which closely looked at SSI associated  
risks for colorectal cancer patients having open surgeries.  The purpose of the study was  
to identify the occurrence and possible determinants of incisional SSI in this population.   
Data were collected by continuous observation, which was maintained for incisional SSI  
for one year on surgeries performed in 2009 by an individual colorectal surgeon.  The  
population selected for the study included patients having elective colorectal resections,  
in which the wound was closed at the end of the procedure.  Patients were excluded if the  
wound was not closed.  Also excluded were patients who were having laparoscopy or  
simple ostomy creation or closure with wedge or segmental resection.  This study  
included a 224 patient cohort, 120 of which were male.  A specific form was filled out by  
the surgeon on incisional SSI for a given patient based on the definition from the Center  
for Disease Control and Prevention (CDC).  Another form was used to identify patient  
demographics and specified factors possibly associated with incisional SSI.  Multivariate  
analysis was used to analyze the possible reasons for incisional SSI in this population.   
Assessment of the surgical incisions was done up to a minimum of 30 days  
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postoperatively.  The specific time of antibiotic administration was documented by the  
anesthesiologist.  For all patients included in this study, administration of antibiotics was  
between 15 and 50 minutes prior to the surgical incision.  The onset of incisional SSI was  
not affected by the timing of preoperative antibiotic administration.  There was no  
significant difference between antibiotic administration 15 to 29 and 30 to 50 minutes  
prior to incision (P = 0.773).  Of the 124 patients who received antibiotic prophylaxis,  
about 29 % developed a SSI.  Many confounding variables were minimized because all  
surgeries were performed by the same surgeon.  A study with more subjects is needed in  
order to provide further evidence on different causes of SSIs (Ishikawa et al.). 
 Nelson et al. (2014) composed a systematic review in order to examine the  
relationship between antibiotic prophylaxis and SSI for patients having colorectal  
surgeries.  Cochrane, Embase, and Medline were used to search for relevant evidence.   
Prophylactic antibiotic treatment done in randomized controlled trials including patients  
having both emergent and elective colorectal surgeries with SSIs were selected for this  
review.  Data were examined by a single reviewer and then rechecked by another  
reviewer for SSI.  The GRADE system was used to evaluate quality.  The review  
included a total of 260 trials and 43,451 participants.  Two related studies compared the  
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administration of antibiotics before surgery to the administration after surgery and no  
notable difference was found (risk ratio [RR] 0.67, 95% CI 0.2-2.15).  Quality of the  
review is considered to be high, however its attrition rate presents a limitation across  
many studies.  The authors advise further research on the timing and dosing of oral  
antibiotics (Nelson et al.).    
 Across the studies and reviews, there are still many questions to be asked and  
answered on this topic.  It seems that there is much uncertainty in relation to prophylactic  
antibiotic administration time.  The findings suggest that there is no definitive answer to  
the question of how timing of prophylactic antibiotic administration effects incisional SSI  
rates.   
Next, the theoretical framework guiding this study will be presented. 
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Theoretical Framework: The Germ Theory 
A theoretical framework widely known as The Germ Theory was initially  
discovered in 1858 by Louis Pasteur (McEwen & Wills, 2011).  Louis Pasteur came up  
with the theory that a certain microorganism could have the ability to cause infection.  It  
was suggested that in order for someone to get an infection, a person first needs to be  
susceptible to a microorganism.  McEwen and Wills explained that someone with an  
increased risk for infection may be a person with a bad burn due to the loss of skin  
protection.  This theory has been extremely influential in the study of medicine and the  
prevention of infection for many years.  Current application of this theory includes  
measures to aid in the prevention of infection such as frequent hand washing and  
antibiotic prophylaxis.  It is also used to recognize and control different infectious  
diseases (McEwen & Wills).  
  After the proposal of The Germ Theory, Louis Pasteur continued his research  
further by studying different diseases including cholera, silkworm disease, rabies, and  
anthrax (Toledo-Pereyra, 2009).  He observed the progression of rabies, found a way to  
vaccinate animals and was successful in creating the first rabies vaccine for humans.  A  
British surgeon named Joseph Lister followed Pasteur’s work and was found to have  
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similar beliefs on surgical infections.  He sent Pasteur a letter in 1874 thanking him for  
his accomplishments with The Germ Theory and explaining how his years of study had  
saved many lives.  Pasteur showed how germs could be detrimental in many different  
situations including when found in wounds.  It has been said that Louis Pasteur gave rise  
to a surgical revolution.  Surgeons today continue to support these fundamentals of  
surgery, which were largely attributed to the work of Louis Pasteur (Toledo-Pereyra). 
 Based on the Germ Theory of Disease by Louis Pasteur, Joseph Lister began to  
use antiseptic techniques for surgery with the use of carbolic acid (Wilson, 1999), which  
was found to kill microorganisms.  Lister further investigated the use of antiseptic  
dressings in the 1860s.  During this time, Lister was able to significantly decrease the  
mortality rate of patients having amputations.  Many people had not initially supported  
his ideas, but the principles that he proposed became accepted over time.  Lister's efforts  
allowed for the first appropriate and believable implementation of The Germ Theory to  
manage infectious disease, which advanced the field of surgery (Wilson).  Even though  
asepsis and sterile technique have replaced antisepsis as the main principle in preventing  
infection, it was Lister’s application of The Germ Theory to surgery that provided the  
foundation for what surgeons currently do.  Through his work, he demonstrated to  
17 
 
physicians and surgeons the necessity of keeping wounds clean and free of  
contamination.  Joseph Lister continues to be an inspiration to surgeons today (Pitt &  
Aubin, 2012).  
 The methodology guiding this systematic review will be presented next.   
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Method 
Purpose/Clinical Question/Outcomes Examined 
 SSIs can often be prevented, however, not all institutions and providers follow the  
same guidelines for timing of antibiotic prophylaxis.  Colorectal surgery is known for  
having a high risk of surgical site infection (SSI).  Based on the type of surgery,  
researchers recommend that appropriate antibiotic timing, dosing, and selection need  
further research.  The clinical question that was addressed is: “In adult surgical patients  
having colorectal surgeries, does prophylactic antibiotic administration time effect  
surgical site infection rates within 30 days of surgery?”  The purpose of this research  
project was to examine the relationship between SSI rates and prophylactic antibiotic  
administration time in adults having colorectal surgeries.   
Inclusion/Exclusion Criteria/Limits 
This systematic review included studies involving adult surgical patients having  
colorectal surgeries with an abdominal incision.  All types of studies are included due to  
the limited amount of research available.  The included research must have delineated  
timing of prophylactic IV antibiotic administration and SSI rates within 30 days of  
surgery.  
19 
 
Exclusion criteria included other than adults, colorectal procedures with no  
incision and evidence of pre-operative infection in any site.  
Procedure 
Literature search.  A comprehensive search of the literature was conducted  
using the following keywords: “Antibiotic Prophylaxis”, “Colorectal Surgery”, “Colon  
Surgery”, “Timing”, “Surgical Site Infection”, and “Surgical Care Improvement  
Program”.  CINAHL, PubMed, Cochrane, and Google Scholar were utilized for an in  
depth literature search.  At the end of the database searches, 21 studies were found.   
Studies were briefly examined to identify which ones best answered the clinical question  
as guided by Fineout-Overholt, Melnyk, Stillwell, and Williamson (2010a; 2010b;  
2010c).  Seven studies were retained for data collection as the others did not meet the  
requirements.  The reference list of each study was examined for additional relevant  
literature.  After reviewing the reference lists of each study, two additional studies were  
obtained, for a total of nine.      
Data Collection.  Relevant data was collected by using a form created by the  
researcher (Appendix A).  The researcher was guided in the development of a data  
extraction tool by Fineout-Overholt et al. (2010a; 2010b; 2010c), Parts i-iii.  Specifically,  
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the year, title, author, type of research and journal were recorded in addition to purpose,  
results, antibiotic administration time, SSI rates, recommendations, and limitations of  
each study.   
Critical Appraisal.  A critical appraisal of the literature was completed following  
guidelines by Fineout-Overholt et al. (2010a; 2010b; 2010c).  The rapid critical appraisal  
began by obtaining full text documents of each study.  Each study was reviewed to  
identify its level of evidence, how well it was performed, and how useful it was to  
practice.  This required use of a critical appraisal guide appropriate for the type of  
research (Fineout-Overholt et al.).  The Critical Appraisal Skills Programme (CASP UK,  
2013) Checklists were used as critical appraisal tools.   The checklists helped to  
determine the answers to three broad questions: “Are the results valid?”, “What are the  
results?”, and “Will the results help locally?”  Specific questions that follow helped the  
researcher address these issues systematically.  The researcher was able to select either,  
“Yes”, “Can’t Tell”, or “No” in response to each question.  Separate checklists were used  
for different levels of designs, which can be found in Tables 1-3 on the following pages. 
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Table 1 
CASP Systematic Review Checklist 
10 Questions    
1). Did the review address a clearly focused question? Yes Can’t Tell No 
2). Did the authors look for the right type of papers? Yes Can’t Tell  No 
3). Do you think all the important, relevant studies were 
included? 
 
Yes Can’t Tell No 
4). Did the review’s authors do enough to assess the quality 
of the included studies? 
 
Yes Can’t Tell No 
5). If the results of the review have been combined, was it 
reasonable to do so? 
 
Yes Can’t Tell No 
6). What are the overall results of the review?    
7). How precise are the results?    
8). Can the results be applied to the local population? Yes Can’t Tell No 
9). Were all important outcomes considered? Yes Can’t Tell  No 
10). Are the benefits worth the harms and costs? Yes Can’t Tell No 
 
(CASP UK, 2013) 
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Table 2 
CASP Randomized Controlled Trial Checklist 
10 Questions    
1). Did the trial address a clearly focused issue? Yes Can’t Tell No 
2). Was the assignment of patients to treatments 
randomized? 
 
Yes Can’t Tell  No 
3). Were patients, health workers and study personnel 
blinded? 
 
Yes Can’t Tell No 
4). Were the groups similar at the start of the trial? Yes Can’t Tell No 
5). Aside from the experimental intervention, were the 
groups treated equally? 
 
Yes Can’t Tell No 
6). Were all of the patients who entered the trial properly 
accounted for at its conclusion? 
 
Yes Can’t Tell No 
7). How large was the treatment effect?    
8). How precise was the estimate of the treatment effect?    
9). Can the results be applied in your context? (or to the 
local population?) 
 
Yes Can’t Tell  No 
10). Were all clinically important outcomes considered? Yes Can’t Tell No 
11). Are the benefits worth the harms and costs? Yes  Can’t Tell  No 
 
(CASP UK, 2013) 
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Table 3 
CASP Cohort Study Checklist 
10 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? 
 
Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? 
 
Yes Can’t Tell No 
5). A. Have the authors identified all important confounding           
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes Can’t Tell No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
 
Yes Can’t Tell No 
7). What are the results of this study?    
8). How precise are the results?    
9). Do you believe the results? Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t Tell No 
11). Do the results of this study fit with other available    
evidence? 
 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
 
   
 
 (CASP UK, 2013) 
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Quality Assessment.  The Critical Appraisal for Summaries of Evidence (CASE) 
worksheet (Foster & Shurtz, 2013) was used to assess quality of evidence.  Summary  
topic, summary method, summary content, and summary application were reviewed for  
each study.  The CASE worksheet is displayed in Table 4 on the following page (Foster  
& Shurtz). 
Data Synthesis 
 The CASP checklists (CASP UK, 2013) were used to compare the selected  
research.  Several checklists were utilized by the researcher depending on the type of  
study being reviewed.  As mentioned previously, all types of research were included in  
the analysis.  Consideration of study quality was also included in the data synthesis.   
Each study was assessed for quality by using the Critical Appraisal for Summaries of  
Evidence (CASE) worksheets (Table 4).  Quality of evidence was compared across  
studies by utilizing this tool (Foster & Shurtz, 2013).      
 The results will be presented next, immediately following Table 4.     
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Table 4 
CASE Worksheet  
Critical Appraisal for Summaries of Evidence (CASE) Worksheet 
*Numbers in evaluation correspond with those assigned to articles in data extraction chart* 
Questions Evaluation 
Summary Topic 
1. Is the summary specific in scope and 
application? 
Yes-  
Not completely- 
No- 
Summary Methods 
2. Is the authorship of the summary 
transparent? 
Yes-  
Not completely- 
No- 
3. Are the reviewer(s)/editor(s) of the 
summary transparent? 
Yes-  
Not completely-  
No-  
4. Are the research methods transparent 
and comprehensive? 
Yes-  
Not completely-  
No- 
5. Is the evidence grading system 
transparent and translatable?  
Yes-  
Not completely-  
No- 
Summary Content 
6. Are the recommendations clear? Yes-  
Not completely- 
No-  
7. Are the recommendations 
appropriately cited? 
Yes- 
Not completely-  
No-  
8. Are the recommendations current? Yes-  
Not completely- 
No- 
9. Is the summary unbiased? Yes-  
Not completely- 
No- 
Summary Application  
10. Can this summary be applied to your 
patient(s)? 
Yes-  
Not completely- 
No- 
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Results 
Overview of and Critical Analysis of Individual Studies  
Timing and decreased incidence of SSI in mixed surgeries were examined by  
Weber et al.1 (2008; Appendix B), who aimed to determine specific information about the  
most appropriate timing for perioperative antibiotic prophylaxis.  Weber et al. organized  
a prospective observational cohort study at a university hospital where timing of  
antimicrobial prophylaxis was examined based on SSI occurrence in 3,836 surgeries.   
Cefuroxime 1.5g was administered as a single dose to each patient along with  
metronidazole 500mg for colorectal surgeries.  Weber et al. demonstrated a decreased  
occurrence of SSI rates when cefuroxime and metronidazole were administered 30 to 60  
minutes before incision for procedures including colorectal surgery.  Analyses showed a  
significant increase in the incidence of SSIs when antibiotic prophylaxis was  
administered during the last half hour of surgery (P < 0.001) and during the last 60 to 120  
minutes of surgery (P = 0.035) as compared with 30 to 59 minutes before surgical  
incision.   
As seen in Appendix C (Weber et al.1), the critical analysis of this cohort study  
was positive based on “yes” answers to all questions, except one.  A confidence interval  
was not listed and it was unclear whether the follow-up of subjects was complete enough  
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because post-discharge monitoring was not performed by outpatient clinics following a  
standard protocol to assess patients.  However, authors do state that due to the three step  
assessment procedure and high follow-up rates of inpatients and outpatients that the  
results are likely unbiased.   
Pastor et al.2 (2010; Appendix B) hypothesized that the incidence of SSI would be  
decreased with the application of SCIP prevention measures.  A multidisciplinary team  
was assembled to put SCIP infection prevention measures into effect and monitor  
adherence.  Study participants included patients having non-emergent colorectal surgeries  
with an abdominal incision.  This study showed an increase in adherence to SCIP  
measures but without a decrease in SSI related to compliance for each individual case.  A  
95% rate of compliance was achieved for timing of antibiotic prophylaxis, identified as  
starting administration within 60 minutes of surgical incision (P = .002).  The SSI rate  
between groups was similar at 18.9 % and 19.4 %.  Overall, there was a 19% rate of SSI  
after elective colorectal surgery.   
As seen in Appendix C (Pastor et al.2) this cohort study did not list a confidence  
interval and included a sample size of 491 patients in a small colorectal unit, which  
limits application to other populations.  However, this study had a very positive critical  
analysis based on the responses seen in Appendix C.    
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One study by Ho et al.3 (2011; Appendix B) attempted to identify adherence to a  
set of guidelines for antibiotic administration and to assess risk for SSIs.  It was  
hypothesized that compliance with the guidelines would decrease the occurrence of SSIs.   
Six hundred five patients having colorectal surgeries with anastomosis between June  
2001 and July 2008 were selected randomly.  Results indicated that increased occurrence  
of SSIs correlated with early administration of prophylactic antibiotics, specifically  
greater than 30 minutes prior to incision (OR 1.725, 95% CI 1.147-2.596).   
This cohort study (Ho et al.3) was found to have merit as the critical analysis  
answers were all “yes” (Appendix C).  A confidence interval of 95% was included, so the  
recommendations may be considered by clinicians such as nurse anesthetists.     
In a study by Hawn et al.4 (2011; Appendix B), SCIP guidelines were  
implemented and evaluated to determine if following the guidelines would result in a  
decreased incidence of SSI rates within 30 days of a surgical procedure.  Data were  
gathered from 2005 to 2009 from the National Veterans’ Affairs Surgical Quality  
Improvement Program (VASQIP) on both compliance to SCIP measures and SSI  
incidence.  This was a retrospective cohort study that also examined adherence to five  
SCIP measures including timely prophylactic antibiotic administration: SCIP-inf 1.  A  
total of 15,444 colorectal surgeries were included in this study.  The overall SSI rate was  
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6.2% and 11.3% for colorectal surgeries.  After adjusting for the procedure and patient  
variables, the results indicated that compliance with the SCIP measures did not correlate  
with a lower incidence of SSI.  For the timely antibiotic measure, an adjusted OR was  
determined to be 0.90 with a 95% CI for 29,042 cases.   
As seen in Appendix C, this cohort study (Hawn et al.4) included a large VA  
population of mostly men, which limits application to women and the local population,  
but otherwise the study included a 95% confidence interval and the answers to the critical  
analysis questions were positive overall.   
 A more recently published study conducted by similar authors focused  
specifically on timing of surgical antibiotic prophylaxis and included subjects from the  
same population as in the earlier study.  Hawn et al.5 (2013; Appendix B) aimed to  
discover the correlation between antibiotic administration time and SSI rates within 30  
days postoperatively.  Antibiotics were administered at a median of 28 minutes before  
surgical incision and 1,497 patients (4.6%) developed an SSI.  In generalized additive  
models adjusted for procedure, patient, and antibiotic variables, no significant correlation  
between prophylactic antibiotic timing and SSI was seen (P = 0.26 - 0.85). This was true  
for 5,469 colorectal surgeries (adjusted OR 0.7; 95% CI).  Therefore, the researchers  
stated that there was not enough evidence to recommend compliance to the timely  
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antibiotic measure.   
This cohort study (Hawn et al.5) also included a large VA population of mostly  
men, so it may not be generalized to women (Appendix C).  The answers to the critical  
analysis questions were all “yes” and a 95% confidence interval was listed by the authors.        
 Ishikawa et al.6 (2014; Appendix B) conducted research which closely looked at  
SSI associated risks for colorectal cancer patients having open surgeries.  The purpose of  
the study was to identify the occurrence and possible determinants of incisional SSI in  
this population.  Data were collected by continuous observation, which was maintained  
for incisional SSI for one year on surgeries performed in 2009 by an individual colorectal  
surgeon.  This study included a 224 patient cohort, 120 of which were male.  For all  
patients included in this study, administration of antibiotics was between 15 and 50  
minutes prior to the surgical incision.  The onset of incisional SSI was not affected by the  
timing of preoperative antibiotic administration.  There was no significant difference  
between antibiotic administration 15 to 29 and 30 to 50 minutes prior to incision  
(P = 0.773).  Of the 124 patients who received antibiotic prophylaxis, about 29 %  
developed a SSI.   
As seen in Appendix C, the cohort study (Ishikawa et al.6) was critically analyzed  
and answers to the questions were all “yes” with the following exceptions:  there was no  
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confidence interval listed by the authors and the study population was smaller than some  
of the others, but overall the critical analysis was positive.     
  Nelson et al.7 (2014; Appendix B) composed a systematic review in order to  
examine the relationship between antibiotic prophylaxis and SSI for patients having  
colorectal surgeries.  Cochrane, Embase, and Medline were used to search for relevant  
evidence.  Prophylactic antibiotic treatment administered in randomized controlled trials  
including patients that had both emergent and elective colorectal surgeries with SSIs were  
selected for this review.  The review included a total of 260 trials and 43,451 participants.   
Two related studies compared the administration of antibiotics before surgery to the  
administration after surgery and no notable difference was found (risk ratio [RR] 0.67,  
95% CI 0.2-2.15).  Two RCTs that were included in this systematic review are described  
below.   
As seen in Appendix C, this systematic review (Nelson et al.7) was critically  
analyzed for strengths and weaknesses.  A systematic review is considered the highest  
level of evidence and this one in particular included the two available RCTs to make  
recommendations (Tornqvist et al.8 & Colizza et al.9).  A 95% confidence interval was  
included and this review had more strengths than weaknesses as can be seen in Appendix  
C.      
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A RCT was completed to study the effect of dosage and duration of antibiotic  
prophylaxis and to discover if postoperative treatment was as effective as preoperative  
treatment (Tornqvist et al.8, 1981; Appendix B).  The authors also aimed to find an  
appropriate method to estimate contamination of the operation area to relate the degree of  
contamination to sepsis postoperatively.  One hundred ninety-six consecutive patients  
having elective colonic surgery were included and randomized into four groups.  All  
patients underwent mechanical bowel preparation in a standardized manner.  Group I  
received doxycycline 200mg IV 1-1.5 hours preoperatively.  Group II received 600mg IV  
1-1.5 hours preoperatively.  Group III received 600mg IV postoperatively in recovery, 2- 
5 hours after colon opening.  Finally, group IV received 200mg IV 1-1.5 hours  
preoperatively and once daily during the first three days postoperatively.  SSI rates  
follow: Group I 13%, Group II 7%, Group III 20%, Group IV 19%.   
In Appendix C, the critical analysis of this RCT (Tornqvist et al.8) can be viewed.   
Answers to the critical analysis questions were all “yes” except it was unclear whether  
patients, health workers, and study personnel were appropriately blinded to the trial,  
which could have impacted the results.  A confidence interval is also not listed by the  
author.  Finally, it is unclear whether this study should be applied to the adult patient  
undergoing colorectal surgery because the results may not be valid if the people included  
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were not appropriately blinded.     
Colizza et al.9 (1987; Appendix B) conducted a RCT of short term antibiotic  
prophylaxis with cefuroxime including 52 patients having elective colorectal surgery.   
The purpose is not stated.  Each patient was randomly assigned to either Group A or  
Group B.  Each patient received a total of 5.250 mg of cefuroxime.  However, Group A  
received 750 mg intramuscularly (IM) preoperatively, 750 mg liquid on the fascia before  
closure of the skin, 750 mg IV right after the end of the procedure and repeated four  
times every 6 hours.  Group B received 750 mg IV right after the end of the procedure  
and repeated six times every 6 hours.  All patients received a standard bowel preparation  
preoperatively.  Wound sepsis was observed in 11.5% of patients in group A and 23% in  
group B, while other types of sepsis were observed in 34.6% of group A and 11.5% of  
group B.  The results indicated that better control of wound sepsis was seen in group A,  
while better protection from other infections or complications was seen in group B.  Only  
52 patients were included in this trial.  Group A included more surgeries that had an  
increased risk of sepsis.  Death occurred for 3 patients likely due to anastomotic leakage.   
As seen in Appendix C, it was unclear what the study purpose was and whether  
all participants were treated equally (Colizza et al.9).  It was also unclear whether  
patients, health workers, and study personnel were blinded to the trial, which could have  
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impacted the results.  There is no confidence interval listed by the authors.  However, the  
majority of the critical analysis questions were answered, “yes”.   
Critical Analysis Across Studies    
The critical analyses of the studies were positive, but the ability to generalize is  
limited overall by the cohort study design of many of the studies.  All of the cohort  
studies (Weber et al.1, Pastor et al.2, Ho et al.3, Hawn et al.4, Hawn et al.5, & Ishikawa et  
al.6) had positive results related to the critical analysis.  However, Pastor et al.2 included  
a sample of patients from a small colorectal unit, which could limit application to other  
populations.  Hawn et al.4 and Hawn et al.5 included larger sample sizes, however the  
studies included a VA population of mostly men, so they may not be generalized to  
women.  The systematic review by Nelson et al.7 based its conclusions on two RCTs  
included in this review (Tornqvist et al.8 & Colizza et al.9; Appendix C).  Tornqvist et al.8  
and Colizza et al.9 do not list any limitations and the trials were completed in the 1980s.   
It is also unclear whether patients, health workers, and study personnel were  
appropriately blinded for these two studies, which could have affected the results.  The  
RCTs are otherwise important to consider due to the level of evidence and the results and  
recommendations should be considered when making decisions on timing of antibiotic  
prophylaxis for colorectal procedures.  Tornqvist el al.8 suggested administering a single  
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preoperative dose of doxycycline 200mg or 600mg IV as the “treatment of choice”.   
Colizza et al.9 recommended short term antibiotic use, including a preoperative  
intramuscular (IM) dose, one intraincisionally, and an IV dose every six hours for 24  
hours beginning immediately after the procedure to reduce the incidence of sepsis  
after elective colorectal surgery. 
 Pastor et al.2, Ho et al.3, Ishikawa et al.6, Nelson et al.7, Tornqvist et al.8, and  
Colizza et al.9 focused solely on colorectal surgery, whereas the others (Weber et al.1;  
Hawn et al.4; Hawn et al.5) included other types of surgery in the analyses.  Weber et al.1,  
Hawn et al.4 and Hawn et al.5 have strengths that are due to the large samples studied  
and the research is current.   
All of the studies included addressed a clear and focused issue (Appendix C).  For  
all of the cohort studies, patient recruitment was appropriate and the exposure and  
outcomes were accurately measured.  The follow-up of patients was determined to be  
long enough and complete enough for all cohort studies except for Weber et al.1, which  
was unclear.  The important confounding factors were clearly identified and considered  
in the analysis of all cohort studies except for Pastor et al.2 The systematic review by  
Nelson et al.7 included all of the relevant available evidence in the form of RCTs  
(Appendix C).  Finally, the purpose was clearly stated for all studies except for Colizza et  
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al.9 (Appendix B).   
Key Comparisons Across Studies: The CASE Worksheet 
Key aspects of a comparison across the studies are discussed below and can be  
found in Appendix D.  Based on comparison across the included studies using the CASE  
worksheet (Foster & Shurtz, 2013), it was found that for all studies the summaries were  
specific in both scope and application.  The authors were identifiable and transparent;  
however, the editors of the summaries were only transparent for Pastor et al.2, Ho et al.3,  
Hawn et al.5, Ishikawa et al.6, and Nelson et al.7.  The research methods for most studies  
were found to be comprehensive and transparent (Weber et al.1; Pastor et al.2; Ho et al.3;  
Hawn et al.4; Hawn et al.5; Ishikawa et al.6; Nelson et al. 7) but not all (Tornqvist et al.8 &  
Colizza et al.9).  The evidence grading system was found to be transparent and easily  
understood for all studies included.   
Summary content was assessed by identifying and confirming clear  
recommendations at the end of each study.  Recommendations were clearly stated in the  
majority (Weber et al.1; Ho et al.3; Hawn et al.4; Ishikawa et al.6; Nelson et al.7; Tornqvist  
et al.8) but not all (Pastor et al.2; Hawn et al.5; Colizza et al.9).  All studies except the  
RCTs by Tornqvist et al.8 and Colizza et al.9 included current recommendations.  All  
summaries except that of Hawn et al.5 were determined to be unbiased.   
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As a group, the results of the quality assessment are overall consistent, however  
the cohort design of many of the studies limits the ability to generalize.  Overall, several  
summaries can be applied to the adult undergoing colorectal surgery with an incision  
(Weber et al.1, Ho et al.3, Ishikawa et al.6).  These cohort studies are specific in scope and  
application, the research methods are clear, recommendations are clear and appropriately  
cited, and the results can be applied to the studied population based on the results of the  
CASE worksheet (Appendix D).  The results of the three cohort studies (Weber et al.1,  
Ho et al.3, Ishikawa et al.6) will be discussed in further detail in the summary and  
conclusions section.  Summaries that can be partially applied are Pastor et al.2, Hawn et  
al.4, Hawn et al.5, Nelson et al.7, Tornqvist et al.8, and Colizza et al.9.  Pastor et al.2 did  
not list clear recommendations, included a sample from a small colorectal unit, and is  
limited to generalization due to the study design.  There was also a change in antibiotic  
prophylaxis selection during the study, which could have impacted the results of the  
study (Appendix B).  Hawn et al.4 and Hawn et al.5 are both cohort studies, which limits  
the ability to generalize due to the design of the studies.  The studies also included a large  
VA population of mostly men, which limits application to women (Appendix D).  The  
systematic review by Nelson et al.7 based its conclusions on the two available RCTs  
(Tornqvist et al.8 & Colizza et al.9) which did not prove to be of great quality based on  
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the results of the CASE worksheet (Appendix D).  However, Tornqvist et al.8 and Colizza  
et al.9 are considered to be a higher level of evidence than the previous cohort studies.   
 Next, the summary and conclusions will be presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
Summary and Conclusions 
Colorectal surgery is known for having a high risk of surgical site infection.  
Surgical site infections can often be prevented; however, not all institutions and providers  
follow the same guidelines for timing of antibiotic prophylaxis.  Previous research  
suggested that administering prophylactic antibiotics prior to colorectal surgery may  
prevent SSIs.  This led to the research question: “In adult surgical patients having  
colorectal surgeries, does prophylactic antibiotic administration time effect surgical site  
infection rates within 30 days of surgery?”  The purpose of this systematic review was to  
examine the relationship between SSI rates and prophylactic antibiotic administration  
time in adults having colorectal surgeries. 
  This systematic review included studies involving adult surgical patients having  
colorectal surgeries with an abdominal incision.  All study designs were included due  
to the limited amount of research available.  The included research must have delineated  
timing of prophylactic IV antibiotic administration and SSI rates within 30 days of  
surgery.  Exclusion criteria included other than adults, colorectal procedures with no  
incision and evidence of pre-operative infection in any site.  
A comprehensive search of the literature was conducted using the following  
keywords: “Antibiotic Prophylaxis”, “Colorectal Surgery”, “Colon Surgery”, “Timing”,  
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“Surgical Site Infection”, and “Surgical Care Improvement Program”.  The search  
engines CINAHL, PubMed, Cochrane, and Google Scholar were utilized.  At the end of  
the database searches, 21 studies were found; these were examined to determine  
eligibility.  Seven studies were retained for data collection and the reference list of each  
study was examined for additional relevant literature.  After reviewing the reference lists  
of each study, two additional studies were obtained, for a total of nine.  
Relevant data were collected by using an extraction form created by the  
researcher.  The researcher was guided in the development of a data extraction tool by  
Fineout-Overholt et al. (2010a).  A copy of the data extraction form is illustrated in  
Appendix A.  Next, a critical appraisal of the literature was completed following  
guidelines by Fineout-Overholt et al. (2010a; 2010b; 2010c).  Each study was reviewed  
to identify its level of evidence, how well it was performed, and how useful it was to  
practice.  This required use of a critical appraisal guide appropriate for the type of  
research (Fineout-Overholt et al.).  The Critical Appraisal Skills Programme (CASP UK,  
2013) Checklists were used as critical appraisal tools (Appendix B).  The checklists  
helped to determine the answers to three broad questions: “Are the results valid?”, “What  
are the results?”, and “Will the results help locally?”  Specific questions that follow  
helped the researcher address these issues systematically.  The researcher was able to  
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select either, “Yes”, “Can’t Tell”, or “No” in response to each question.  Separate  
checklists were used for different levels of designs, which can be found in the Tables 1-3  
above.  The Critical Appraisal for Summaries of Evidence (CASE) worksheet (Foster &  
Shurtz, 2013) was used to assess quality of evidence across the studies.  Summary topic,  
summary method, summary content, and summary application were reviewed for each  
study (Appendix D).  
 Limitations of this systematic review were based on the available evidence, which  
were mostly cohort studies.  First, there was very little level I or II evidence.  Though a  
systematic review was included in this research, it only included two RCTs which were  
quite dated and did not include all of the important considerations based on the results  
shown in Appendix C.  There were no limitations noted by authors of either of the RCTs.   
One of the trials (Colizza et al.9) did not include the purpose of carrying out the  
experiment.  In another study (Weber et al.1), confounding of findings by unmeasured  
variables could not be ruled out completely due to the observational nature of the study.   
Some of the studies included more men than women (Hawn et al.4 & Hawn et al.5)  
making the generalization to women more difficult. 
In conclusion, three summaries were identified that can be cautiously applied to  
the adult undergoing colorectal surgery (Weber et al.1, Ho et al.3, Ishikawa et al.6).  These  
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cohort studies are specific in scope and application, the research methods are clear,  
recommendations are clear and appropriately cited, and the results can be applied to the  
studied population based on the results of the CASE worksheet (Appendix D).  Weber et  
al.1 demonstrated a decreased occurrence of SSI rates when cefuroxime and  
metronidazole were administered 30 to 60 minutes before incision for procedures  
including colorectal surgery.  Analyses showed a significant increase in the incidence of  
SSIs when antibiotic prophylaxis was administered during the last half hour of surgery  
and during the last 60 to 120 minutes of surgery as compared with 30 to 59 minutes  
before surgical incision.  As seen in Appendix C (Weber et al.1), the critical analysis of  
this cohort study was positive based on “yes” answers to all questions, except one.   
The research method was found to be comprehensive and transparent and the evidence  
grading system was found to be easily understood.  
The cohort study by Ho et al.3 (2011) attempted to identify adherence to a  
set of guidelines for antibiotic administration and to assess risk for SSIs.  Results  
indicated that increased occurrence of SSIs correlated with early administration of  
prophylactic antibiotics, specifically greater than 30 minutes prior to incision.  This  
cohort study was found to have merit as the critical analysis answers were all “yes”  
(Appendix C).  A confidence interval of 95% was included, so the recommendations may  
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be considered by clinicians.  
 Ishikawa et al.6 (2014) conducted research which closely looked at SSI associated  
risks for colorectal cancer patients having open surgeries.  For all patients included in this  
study, administration of antibiotics was between 15 and 50 minutes prior to the surgical  
incision.  The onset of incisional SSI was not affected by the timing of preoperative  
antibiotic administration.  There was no significant difference between antibiotic  
administration 15 to 29 and 30 to 50 minutes prior to incision.  Of the 124 patients who  
received antibiotic prophylaxis, about 29 % developed a SSI.  As seen in Appendix C, the  
cohort study was critically analyzed and answers to the questions were all “yes” with the  
following exceptions:  there was no confidence interval listed by the authors and the  
study population was smaller than some of the others, but overall the critical analysis was  
positive.   
 Results indicated that there is insufficient evidence to support a definite course  
of action for timing of antibiotic prophylaxis for colorectal surgery at this time.  Further  
randomized controlled trials are needed.  The certified registered nurse anesthetist  
(CRNA) should be aware of the recommendations to administer antibiotic prophylaxis  
for colorectal surgery before the surgical incision based on the results of this systematic  
review as timing of administration can affect SSI rates.  It is recommended to carefully  
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consider antibiotic selection and timing when administering antibiotics prophylactically  
for colorectal surgery. 
Next, the recommendations and implications for advanced nursing practice will  
be presented. 
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Recommendations and Implications for Advanced Nursing Practice 
Ultimately, the aim in relation to surgeries, including colorectal surgeries, should  
be to administer antibiotics at the optimal time despite practical difficulties (Weber et  
al.1). Oral antibiotic prophylaxis and mechanical bowel prep for colorectal surgery  
should also be further researched (Pastor et al.2).  Appropriate antibiotic selection and  
timing of administration for prophylaxis are believed to be important factors to decrease  
the likelihood of SSI elective colorectal surgery with intestinal anastomosis (Ho et al.3).   
Although the SCIP measures are best practices and should continue, using them to direct  
patients to high and low performing hospitals is not appropriate and could be misleading  
(Hawn et al.4).  In addition, the authors of one study (Hawn et al.5) concluded that there  
was not enough evidence to support compliance to the SCIP measure for timing of  
antibiotic prophylaxis (administration within 60 minutes of surgical incision).  It is also  
important to consider the many variables that can affect timing of antibiotic prophylaxis  
such as patient population, antibiotic selection, and repeat dosing (Hawn et al.5).  A single  
preoperative dose of Doxycycline has been recommended as the choice treatment for  
antibiotic prophylaxis to decrease the infection rate in colon surgery; however, this study  
is dated and should be repeated with a larger sample size and consideration of all  
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confounding factors (Tornqvist et al.8).  Short term prophylactic cephalosporin  
administration also may be helpful in decreasing the incidence of sepsis after elective  
colorectal surgery (Colizza et al.9).  The differences in results of research on this topic  
may be due to the population of patients selected rather than the type of antibiotic used  
(Colizza et al.9). 
 Based on the results of this review, there are various recommendations related to  
timing of antibiotic prophylaxis for colorectal surgery.  There is not enough evidence to  
support a definite course of action for timing of antibiotic prophylaxis at this time.  It is  
recommended by several authors that further research be conducted in the form of RCTs.   
A study with a larger sample size is necessary to provide evidence of risk factors for  
surgical site infection after open colorectal surgery (Ishikawa et al.6).  Modification of  
existing recommendations on timing of surgical antibiotic prophylaxis may be necessary.   
The CRNA should be aware of the recommendations for appropriate antibiotic  
prophylaxis for colorectal surgery as timing of administration can affect SSI rates.   
Surgical site infections can also be very costly and timing of antibiotic prophylaxis can be  
a contributing factor.  At this time, is it recommended to follow the current policies of  
each institution related to the timing of administration of antibiotic prophylaxis for  
colorectal surgery.  It is necessary for the CRNA to be considerate of and be educated on  
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antibiotic selection and patient population when administering antibiotics  
prophylactically for colorectal surgery.  For example, some antibiotics like vancomycin  
need to be administered over a longer period of time and started much earlier than other  
antibiotics.   
 The CRNA is responsible to check the surgeon’s antibiotic orders in the patient’s  
chart and make sure the antibiotic is available.  The appropriate antibiotic dose must then  
be administered according to the institution’s policy.  Education should be completed  
during clinical training related to antibiotic selection, administration time, and dosing for  
this type of surgery.  It is the responsibility of the CRNA to remain current in practice  
and up-to-date in regard to evidence-based practice changes.   
Further research is needed related to antibiotic administration time, route of  
administration, re-dosing, and antibiotic selection in this and other patient populations.   
Randomized controlled trials are critically needed to address the questions that remain.   
Finally, the CRNA has the knowledge and skills to be actively involved in clinical trials  
and to become actively involved in professional organizations that have the ability to  
impact available research funding and relevant policy agendas. 
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Appendix A 
Extraction Form 
 
Title of Study: 
 
Author(s):  
 
Type of Research: 
 
Journal and Year: 
 
Purpose: 
 
Antibiotic Administration Time(s): 
 
Surgical Site Infection Rate: 
 
Author Noted Limitations: 
 
Recommendations: 
 
Results: 
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Appendix B 
Extraction Form 
 
Title of Study #1- The Timing of Surgical Antimicrobial Prophylaxis 
 
Author(s): Walter P. Weber, MD., Walter R. Marti, MD, FACS, Marcel Zwahlen, PdD, Heidi 
Misteli, MD, Rachel Rosenthal, MD, Stefan Reck, MD, Philipp Fueglistaler, MD, Martin 
Bolli, MD, Andrej Trampuz, MD, Daniel Oertli, MD, FACS, & Andreas F. Widmer, MD 
 
Type of Research: Prospective Observational Cohort Study 
 
Journal and Year: Annals of Surgery, 2008 
 
Purpose: To obtain precise information on the best time window for surgical antimicrobial 
prophylaxis. 
 
Antibiotic Administration Time(s): 0-14 minutes before, 15-29 minutes before, 30-44 minutes 
before, 45-59 minutes before, 60-74 minutes before, and 75-120 minutes before. 
 
Surgical Site Infection Rate: 4.7% (180 of 3,836) 
 
Author Noted Limitations: Not high level evidence, a prospective cohort study exploring a 
consecutive series of surgeries. Residual confounding of findings by unmeasured factors 
cannot ever be ruled out entirely in observational studies.  The optimal time for antibiotic 
prophylaxis may not be generalized to all antimicrobials or antibiotics.   
Recommendations: Modify existing recommendations of timing of surgical antibiotic 
prophylaxis.  The aim should be to apply prophylaxis at the optimal time, despite practical 
difficulties.  Administer Cefuroxime 30-59 minutes before incision.    
 
Results: 180 Surgical Site Infections (SSIs) out of 3,836 procedures.  Lowest rate of SSI was 
when antibiotic administration was 30-74 minutes before surgery.  Cefuroxime as a 
prophylactic antibiotic administered 30-59 minutes before incision is more effective than 
during the last ½ hour.   
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Appendix B 
Extraction Form 
 
Title of Study #2- An Increase in Compliance With the Surgical Care Improvement Project 
Measures Does Not Prevent Surgical Site Infection in Colorectal Surgery 
 
Author(s): Carlos Pastor, M.D., Avo Artinyan, M.D., Madhulika G. Varma, M.D., Edward 
Kim, M.D., Laurel Gibbs, M.T., Julio Garcia-Aguilar, M.D., Ph.D. 
 
Type of Research: Prospective Cohort Study  
 
Journal and Year: Diseases of the Colon & Rectum, 2010 
 
Purpose: To test the hypothesis that an increased compliance with quality process measures 
decreases the rate of SSIs in patients having colorectal surgeries.  
 
Antibiotic Administration Time(s): Within 1 hour of incision (SCIP process measure) 
 
Surgical Site Infection Rate: 99 patients (19%) developed SSI out of 491 patients  
 
Author Noted Limitations: Small sample size of 491, small colorectal unit, limits application 
to other populations, and compliance was already relatively high before the start of the study. 
There was a change in antibiotic prophylaxis selection during the study. 
 
Recommendations: Oral antibiotic prophylaxis and mechanical bowel prep for colorectal 
surgery should be further researched.  More realistic expectations recommended.  
 
Results: Increased compliance with the SCIP measures does not result in decreased SSI rates. 
99 patients with SSIs (19%) 
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Appendix B 
Extraction Form 
 
Title of Study #3- Antibiotic Regimen and the Timing of Prophylaxis Are Important for 
Reducing Surgical Site Infection after Elective Colorectal Surgery 
 
Author(s): Vanessa P. Ho, Philip S. Barie, Sharon L. Stein, Koiana Trencheva, Jeffrey W. 
Milsom, Sang W. Lee, and Toyooki Sonoda  
 
Type of Research: Retrospective Review-prospective database of a random sample 
 
Journal and Year: Surgical Infections, 2011 
Purpose: To determine compliance with an antibiotic administration protocol including 
regimen, initial dose, timing, and redosing. A second aim is to determine the risk of SSI 
associated with each of the previous measures.   
 
Antibiotic Administration Time(s): Greater than 30 minutes prior to incision, within 30 
minutes of incision, and after the incision. 
 
Surgical Site Infection Rate: 76 patients (12.6%) superficial or deep incisional SSI, 54 patients 
(8.9%) organ/space SSI.  Overall SSI rate- 21.5% 
 
Author Noted Limitations: Retrospective nature, bowel preparation unknown for each patient, 
small sample size of 605 patients, administration by anesthesiologists instead of nurses to 
decrease SSI incidence for the study. 
 
Recommendations: Future research should continue to focus on optimal prophylaxis regimens 
and timing.  Changes in clinical outcomes should be followed with the implementation of 
quality control measures.  
 
Results: Overall SSI rate- 21.5%. Increased occurrence of SSI with administration of 
prophylactic antibiotics greater than 30 minutes before incision. 
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Appendix B 
Extraction Form 
 
Title of Study #4- Surgical Site Infection Prevention: Time to Move Beyond the Surgical Care 
Improvement Program 
 
Author(s): Mary T. Hawn, MD, MPH, Catherine C. Vick, MS, Joshua Richman, MD, PhD, 
William Holman, MD, Rhiannon J. Deierhoi, MPH, Laura A. Graham, MPH, William G. 
Henderson, MPH, PhD, & Kamal M.F. Itani, MD  
 
Type of Research: Retrospective Cohort Study 
 
Journal and Year: Annals of Surgery, 2011 
 
Purpose: To evaluate whether the SCIP improved SSI rates using national data at the patient 
level for both SCIP adherence and SSI occurrence.   
 
Antibiotic Administration Time(s): Administration within 60 minutes of incision (120 minutes 
for Vancomycin and Fluoroquinolones).  
 
Surgical Site Infection Rate: 6.2%  
 
Author Noted Limitations: Evaluation of VA population, mainly men, so may not be 
generalized to women. Limited ability to measure “secular effects” of the program prior to its 
implementation at the VA.   
 
Recommendations: Although the processes measured are best practices and should continue, 
using them to discriminate between high and low performing hospitals is not recommended.   
 
Results: Implementation of the SCIP infection prevention measures did not improve the rate of 
SSIs.  Using these measures to send patients to high quality hospitals could be misleading.   
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Appendix B 
Extraction Form 
 
Title of Study #5- Timing of Surgical Antibiotic Prophylaxis and the Risk of Surgical Site 
Infection 
 
Author(s): Mary T. Hawn, MD, MPH, Joshua S. Richman, MD, PhD, Catherine C. Vick, MS, 
Rhiannon J. Deierhoi, MPH, Laura A. Graham, MPH, William G. Henderson, MPH, PhD, 
Kamal M.F. Itani, MD  
 
Type of Research: Retrospective Cohort Study 
 
Journal and Year: JAMA, 2013 
Purpose: To determine whether prophylactic antibiotic timing is associated with surgical site 
infection (SSI) occurrence.  
 
Antibiotic Administration Time(s): 16-23 minutes before incision for colorectal surgeries, 
within 60 minutes, greater than 60 minutes. 
 
Surgical Site Infection Rate: 4.6% (1,497 cases developed an SSI) 
 
Author Noted Limitations: More men than women included in the study, so generalization to 
women may not apply.  
 
Recommendations: Further research is needed on antibiotic selection and repeat dosing.  Not 
enough evidence to recommend compliance to the SCIP measure for timing of antibiotic 
prophylaxis.  Several variables can affect timing including patient population and antibiotic 
choice.   
 
Results: 4.6 % or 1,497 out of 32,459 patients developed a SSI.  There were higher SSI rates 
when antibiotic was administered greater than 60 minutes prior to incision, but not after 
incision. It was determined that there was no significant association between prophylactic 
antibiotic timing and SSI. 
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Appendix B 
Extraction Form 
 
Title of Study #6- Incisional Surgical Site Infection after Elective Open Surgery for Colorectal 
Cancer 
 
Author(s): Kosuke Ishikawa, Takaya Kusumi, Masao Hosokawa, Yasunori Nishida, Sosuke 
Sumikawa, and Hiroshi Furukawa  
 
Type of Research: Prospective Surveillance Study  
Journal and Year: International Journal of Surgical Oncology, 2014 
Purpose: To clarify the incidence and risk factors of incisional SSI in patients having elective 
open surgery for colorectal cancer.   
 
Antibiotic Administration Time(s): 15-29 minutes before incision and 30-50 minutes before 
incision 
 
Surgical Site Infection Rate: 33 patients diagnosed with incisional SSI (14.7%) 
 
Author Noted Limitations: Need larger study/cohort 
 
Recommendations: A study with more subjects is necessary to provide evidence of risk factors 
for incisional SSI 
 
Results: 224 patients were evaluated, 33 patients had incisional SSI (14.7%). No significant 
difference between administration of antibiotics 15-29 minutes or 30-50 minutes before 
incision in the development of incisional SSI. 
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Appendix B 
Extraction Form 
 
Title of Study #7- Antimicrobial Prophylaxis for colorectal surgery 
 
Author(s): Richard L. Nelson, Ed Gladman, and Marija Barbateskovic 
 
Type of Research: Systematic Review 
 
Journal and Year: Cochrane Database of Systematic Reviews, 2014 
 
Purpose: To establish the effectiveness of antimicrobial prophylaxis for the prevention of 
surgical wound infection in patients undergoing colorectal surgery. 
 
Antibiotic Administration Time(s): Before surgery and after surgery 
 
Surgical Site Infection Rate: Not listed. See included RCTs for SSI rates (Tornqvist et al., 
1981; Colizza et al., 1987). 
 
Author Noted Limitations: Only two randomized controlled trials (RCTs) included to support 
recommendations (1980s), weak RCTs according to authors. 
Recommendations: See RCTs for recommendations (Tornqvist et al., 1981; Colizza et al., 
1987) 
 
Results: No notable difference was found in antibiotic administration before or after surgery. 
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Appendix B 
Extraction Form 
 
Title of Study #8- Single dose doxycycline prophylaxis and peroperative bacteriological 
culture in elective colorectal surgery 
 
Author(s): A. Tornqvist, G. Ekelund, A. Forsgren, L. Leandoer, S. Olson, and I. Ursing.  
Type of Research: Randomized Controlled Trial  
Journal and Year: British Journal of Surgery, 1981 
 
Purpose: 1- To study the effect of dosage and duration of antibiotic prophylaxis and to 
discover if postoperative treatment was as effective as preoperative treatment. 
2- Find an appropriate method to estimate contamination of the operation area to relate the 
degree of contamination to sepsis/infection postoperatively.   
 
Antibiotic Administration Time(s): 1: 200mg IV 1-1.5 hours preoperatively; 2: 600mg IV 1-
1.5 hours preoperatively; 3: 600mg IV postoperatively in recovery 2-5 hours after colon 
opening; 4: 200mg IV 1-1.5 hours preoperatively and every day during the first 3 days 
postoperatively.  
 
Surgical Site Infection Rate: Group 1: 13%, Group 2: 7%, Group 3: 20%, Group 4: 19% 
 
Author Noted Limitations: None listed by authors 
Recommendations: A single preoperative dose of doxycycline 200mg or 600mg IV is 
recommended as the “treatment of choice”.  A single administration of doxycycline 
considerably reduces the infection rate in colon surgery.  
 
Results: SSI rates- Group 1: 13% with 1 anastomotic dehiscence with wound rupture, Group 2: 
7%, Group 3: 20% with 1 anastomotic dehiscence, Group 4: 19% with 2 anastomotic 
complications; 1 fatal.  Two deaths overall with no signs or symptoms that could be attributed 
to administration of doxycycline.   
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Appendix B 
Extraction Form 
 
Title of Study #9- Short-Term Prophylaxis with Cefuroxime in Colorectal Surgery for Cancer 
Author(s): S. Colizza, M.D., S. De Fazio, M.D., A. Addari, M.D., R. Grande, M.D., and G. 
Cucchiara, M.D. 
 
Type of Research: Randomized Controlled Trial 
Journal and Year: Journal of Surgical Oncology, 1987 
Purpose: Not stated 
Antibiotic Administration Time(s): Group A: 750mg IM preoperatively, 750mg topically 
before skin closure, and 750mg IV immediately after surgery and repeated every 6 hours x 4. 
Group B: 750mg IV immediately after surgery and repeated every 6 hours x 6 (only 
postoperatively administered). 
 
Surgical Site Infection Rate: “Wound Sepsis”-several types  
Wound Sepsis: Group A- 11.5%, Group B- 23%; Other Types: Group A- 34.6%, Group B-
11.5% 
Author Noted Limitations: None described by authors. 
Recommendations: Short term cephalosporin use may be helpful in reducing the incidence of 
sepsis after elective colorectal surgery. Differences in research on this topic (results) may be 
due to the selection of patients rather than type of antibiotic used. 
 
Results: Overall operative mortality= 5.7% or 3 cases (not statistically significant).  Additional 
antibiotics were given to 7 patients from Group A and 4 patients from Group B (also not 
significant).  Short term prophylactic cephalosporins can be useful in decreasing the incidence 
of sepsis after elective colorectal surgery.  Treatment A: Better control of wound sepsis. 
Treatment B: Better protection from other infections/complications-significantly less 
infectious complications than Group A.  
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Appendix C 
CASP Cohort Study Checklist- Study #1 (Weber et al., 2008) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? 
 
Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? 
 
Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
Yes 
Yes 
Can’t 
Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? SSI rate 4.7% (180 of 
3,836)  
   
8). How precise are the results? No CI given     
9). Do you believe the results? Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t Tell No 
11). Do the results of this study fit with other available    
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
The aim should be to administer antibiotic prophylaxis at 
the optimal time, despite practical difficulties. When 
cefuroxime is given for antibiotic prophylaxis, 
administration 59 - 30 minutes prior to incision is more 
effective than giving it during the last half hour. 
   
 
(CASP UK, 2013) 
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Appendix C 
CASP Cohort Study Checklist- Study #2 (Pastor et al., 2010) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes 
Yes 
Can’t 
Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
B. Was the follow up of subjects long enough? 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? 99 patients (19%) 
developed SSI out of 491 patients. This study showed an 
increase in adherence to SCIP measures but without a 
decrease in SSI related to compliance for each individual 
case. 
   
8). How precise are the results? No CI listed     
9). Do you believe the results?  Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t Tell No 
11). Do the results of this study fit with other available    
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
The practice of oral antibiotic prophylaxis and mechanical 
bowel preparation for colorectal surgery should be 
further researched.  The sample size was somewhat small, 
limiting its application to other populations. Other 
variables such as supplemental oxygen need to be included 
in future research. 
   
 
 (CASP UK, 2013) 
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Appendix C 
CASP Cohort Study Checklist- Study #3 (Ho et al., 2011) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? 76 patients (12.6%) 
with superficial of deep incisional SSI; 54 patients (8.9%) 
with organ/space SSI. Total = 21.5% 
Increased occurrence of SSI with administration >30 
minutes of incision. 
   
8). How precise are the results? 95% CI    
9). Do you believe the results?  Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t Tell No 
11). Do the results of this study fit with other available          
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
The goal of antibiotic prophylaxis for surgery is to 
maintain an adequate and appropriate level of antibiotic 
exposure during the procedure.  Future research should 
focus on optimal antibiotic prophylaxis regimens and 
timing as it is crucial to prevent SSIs in elective abdominal 
colorectal surgery.  
   
 
(CASP UK, 2013) 
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Appendix C 
CASP Cohort Study Checklist- Study #4 (Hawn et al., 2011) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? Implementation of the 
SCIP infection prevention measures did not improve the 
rate of SSI.  SSI rate at 30 days = 6.2% 
11.3% for colorectal surgeries 
   
8). How precise are the results? 95% CI    
9). Do you believe the results?  Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t 
Tell 
No 
11). Do the results of this study fit with other available    
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
Using the SCIP measures to send patients to high quality 
hospitals could be misleading.  Be aware only VA 
population and mostly male patients included, so may not 
be generalized to women.   
   
 
 (CASP UK, 2013) 
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Appendix C 
CASP Cohort Study Checklist- Study #5 (Hawn et al., 2013) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? 1,497 patients (4.6%) 
developed a SSI. No significant association between 
prophylactic antibiotic administration time and SSI.  
   
8). How precise are the results? 95% CI    
9). Do you believe the results? Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t 
Tell 
No 
11). Do the results of this study fit with other available    
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
Be aware only VA population of mostly men included so 
may not be able to generalize to women.  Not enough 
evidence available to recommend compliance to the SCIP 
measure for timing of antibiotic prophylaxis. Several 
variables can affect timing including patient population 
and antibiotic used.   
   
 
(CASP UK, 2013) 
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Appendix C 
CASP Cohort Study Checklist- Study #6 (Ishikawa et al., 2014) 
12 Questions     
1). Did the study address a clearly focused issue? Yes Can’t Tell No 
2). Was the cohort recruited in an acceptable way? Yes Can’t Tell  No 
3). Was the exposure accurately measured to minimize bias? Yes Can’t Tell No 
4). Was the outcome accurately measured to minimize bias? Yes Can’t Tell No 
5). A. Have the authors identified all important confounding 
factors? 
     B. Have they taken account of the confounding factors in 
the design and/or analysis? 
 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
6). A. Was the follow up of subjects complete enough? 
     B. Was the follow up of subjects long enough? 
Yes 
Yes 
Can’t Tell 
Can’t Tell 
No 
No 
7). What are the results of this study? 33 patients were 
(14.7%) diagnosed with incisional SSI. There was no 
significant difference between administration 15 - 29 
minutes and 30 - 50 minutes before incision in the 
development of SSI (P = 0.773).  
   
8). How precise are the results? No CI listed for this 
measure.  
   
9). Do you believe the results?  Yes Can’t Tell  No 
10). Can the results be applied to the local population? Yes Can’t Tell No 
11). Do the results of this study fit with other available    
evidence? 
Yes  Can’t Tell  No 
12). What are the implications of this study for practice? 
A larger study is necessary to provide definitive evidence 
of risk factors for incisional SSI.   
   
 
 (CASP UK, 2013) 
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Appendix C 
CASP Systematic Review Checklist- Study #7 (Nelson et al., 2014) 
10 Questions    
1). Did the review address a clearly focused question? Yes Can’t Tell No 
2). Did the authors look for the right type of papers? Yes Can’t Tell  No 
3). Do you think all the important, relevant studies were 
included? 
Yes Can’t Tell No 
4). Did the review’s authors do enough to assess the quality 
of the included studies? 
 
Yes Can’t Tell No 
5). If the results of the review have been combined, was it 
reasonable to do so? 
 
Yes Can’t Tell No 
6). What are the overall results of the review? Two small 
studies (RCTs) compared giving antibiotics before or 
after surgery and no significant difference was found. 
   
7). How precise are the results? RR 0.67, 95% CI     
8). Can the results be applied to the local population? Yes Can’t Tell No 
9). Were all important outcomes considered? Yes Can’t Tell  No 
10). Are the benefits worth the harms and costs? Yes Can’t Tell No 
 
(CASP UK, 2013) 
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Appendix C 
CASP Randomized Controlled Trial Checklist- Study #8 (Tornqvist et al., 1981) 
11 Questions    
1). Did the trial address a clearly focused issue? Yes Can’t Tell No 
2). Was the assignment of patients to treatments 
randomized? 
 
Yes Can’t Tell  No 
3). Were patients, health workers and study personnel 
blinded? 
 
Yes Can’t 
Tell 
No 
4). Were the groups similar at the start of the trial? Yes Can’t Tell No 
5). Aside from the experimental intervention, were the 
groups treated equally? 
 
Yes Can’t Tell No 
6). Were all of the patients who entered the trial properly 
accounted for at its conclusion? 
 
Yes Can’t Tell No 
7). How large was the treatment effect? SSI rates 
measured--Group I: 13% (6/47); Group II: 7% (3/42); 
Group III: 20% (7/35); Group IV: 19% (8/42). Total SSI 
rate--15% (24/166) 
   
8). How precise was the estimate of the treatment effect? 
No confidence limits, no statistical results listed. 
   
9). Can the results be applied in your context? (or to the 
local population?) 
 
Yes Can’t 
Tell  
No 
10). Were all clinically important outcomes considered? Yes Can’t Tell No 
11). Are the benefits worth the harms and costs? Yes  Can’t Tell  No 
 
(CASP UK, 2013) 
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Appendix C 
CASP Randomized Controlled Trial Checklist- Study #9 (Colizza et al., 1987) 
11 Questions    
1). Did the trial address a clearly focused issue? Yes Can’t Tell No 
2). Was the assignment of patients to treatments 
randomized? 
 
Yes Can’t Tell  No 
3). Were patients, health workers and study personnel 
blinded? 
 
Yes Can’t 
Tell 
No 
4). Were the groups similar at the start of the trial? Yes Can’t Tell No 
5). Aside from the experimental intervention, were the 
groups treated equally? 
 
Yes Can’t 
Tell 
No 
6). Were all of the patients who entered the trial properly 
accounted for at its conclusion? 
 
Yes Can’t Tell No 
7). How large was the treatment effect? SSI rates 
measured--Wound Sepsis: Group A 11.5% (3/26), 
Group B 23% (6/26).  Other Sepsis: Group A 34.6% 
(9/26), Group B 11.5% (3/26).  
   
8). How precise was the estimate of the treatment effect? 
No CI listed. Statistical significance of wound sepsis P < 
0.01, other sepsis P < 0.001 
   
9). Can the results be applied in your context? (or to the 
local population?) 
 
Yes Can’t 
Tell  
No 
10). Were all clinically important outcomes considered? Yes Can’t Tell No 
11). Are the benefits worth the harms and costs? Yes  Can’t Tell  No 
 
(CASP UK, 2013) 
 
 
72 
 
Appendix D 
CASE Worksheet: Comparison Across Studies  
Critical Appraisal for Summaries of Evidence (CASE) Worksheet 
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart* 
Questions Evaluation Studies 1 - 9 
Summary Topic 
1. Is the summary specific in scope and 
application? 
Yes-1,2,3,4,5,6,7,8,9 
Not completely- 
No- 
Summary Methods 
2. Is the authorship of the summary 
transparent? 
Yes-1,2,3,4,5,6,7,8,9  
Not completely- 
No- 
3. Are the reviewer(s)/editor(s) of the 
summary transparent? 
Yes-2,3,5,6,7 
Not completely-  
No-1,4,8,9 
4. Are the research methods transparent 
and comprehensive? 
Yes-1,2,3,4,5,6,7, 
Not completely-8,9 
No- 
5. Is the evidence grading system 
transparent and translatable?  
Yes-1,2,3,4,5,6,7,8,9 
Not completely-  
No- 
Summary Content 
6. Are the recommendations clear? Yes-1,3,4,6,7,8 
Not completely-2,5,9 
No-  
7. Are the recommendations 
appropriately cited? 
Yes-1,3,4,6,7,8 
Not completely-2,5  
No-9 
8. Are the recommendations current? Yes- 1,2,3,4,5,6,7 
Not completely- 
No-8,9 
9. Is the summary unbiased? Yes-1,2,3,4,6,7,8,9 
Not completely-5 
No- 
Summary Application  
10. Can this summary be applied to your 
patient(s)? 
Yes-1,3,6 
Not completely-2,4,5,7,8,9 
No 
 
 
 
 
